Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583791 · ClinicalTrials.gov registry record · NA
Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT00583791 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 91 participants.
The verdict
NCT00583791, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
The objective is to investigate the safety of the AMPLATZER Muscular VSD Occluder for the treatment of muscular ventricular septal defects, which are hemodynamically significant and are either isolated or in conjunction with other congenital heart defects in infants and children.
Interventions
- DEVICE Device closure with the AMPLATZER Muscular VSD Occluder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2000-07 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00583791
The ClinicalTrials.gov registry entry for NCT00583791 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Device closure with the AMPLATZER Muscular VSD Occluder is the first listed.
NCT00583791 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00583791 about?
NCT00583791 is a clinical study titled "Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder". The objective is to investigate the safety of the AMPLATZER Muscular VSD Occluder for the treatment of muscular ventricular septal defects, which are hemodynamically significant and are either isolated or in conjunction with other congenital heart defects in infants and children.
What is the current status of trial NCT00583791?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2000-07. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00583791?
The interventions under investigation include: Device closure with the AMPLATZER Muscular VSD Occluder (DEVICE).
Who is sponsoring clinical trial NCT00583791?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.